Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)
J9 · Effective Dec 30, 2019
29 active Medicare policies list D89.49, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Dec 30, 2019
JH · Effective Dec 30, 2019
JL · Effective Dec 30, 2019
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
3 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D89.49 |
|---|---|---|
| Aldesleukin (Proleukin) | Sep 21, 2023 | Covered |
| Polymerase Chain Reaction Testing: Selected Indications | Feb 9, 2024 | Covered |
| Policy | Effective | Status of D89.49 |
|---|---|---|
| Polymerase Chain Reaction Respiratory Viral Panel Testing | Not recorded | Covered |
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
J6 · Effective Aug 1, 2022
JK · Effective Aug 1, 2022
J9 · Effective Jul 11, 2021
JK · Effective Dec 1, 2021
JH · Effective Jul 11, 2021
JL · Effective Jul 11, 2021
National · Effective Jul 1, 2025
National · Effective Jul 1, 2025
National · Effective Oct 1, 2026
National · Effective Aug 6, 2026
National · Effective Aug 6, 2026
National · Effective May 14, 2026
J5 · Effective Aug 6, 2026
J6 · Effective Apr 1, 2026
National · Effective Jan 1, 2026
National · Effective Jan 1, 2026
National · Effective Apr 1, 2026